Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Aviation Accidents
Riots
Artificial Intelligence
Donald Trump
Immigration
Immigration and Customs Enforcement
Social Media
US Immigration
World Cup
Soccer
Bola Tinubu
US Politics
Published • loading... • Updated

Argenx says its drug Vyvgart looks promising in two more autoimmune diseases

Summary by endpoints.news
The Dutch biotech argenx has big plans for its autoimmune disease drug Vyvgart, which is approved for three conditions and is being tested in a dozen more. On Tuesday evening, it announced ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
endpoints.newsendpoints.news

Argenx says its drug Vyvgart looks promising in two more autoimmune diseases

The Dutch biotech argenx has big plans for its autoimmune disease drug Vyvgart, which is approved for three conditions and is being tested in a dozen more. On Tuesday evening, it announced ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Wednesday, June 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Netherlands

Netherlands

News
For You
SearchBlindspotLocal